Skip to content
ProPublica Donate
ProPublica Donate

United States Pharmacopeial Convention Inc

Organization summary

Type of Nonprofit

Designated as a Organizations for any of the following purposes: religious, educational, charitable, scientific, literary, testing for public safety, fostering national or international amateur sports competition (as long as it doesn't provide athletic facilities or equipment), or the prevention of cruelty to children or animals.

Category: Health — General and Rehabilitative / Research Institutes and/or Public Policy Analysis (NTEE)

Donations to this organization are tax deductible.

Summary charts: organization finances over time

Revenue
$354M (2024)

Expenses
$330M (2024)

Total Assets
$751M (2024)

Total Liabilities
$188M (2024)

Source: Form 990 tax filings from 2011 to 2024

Tax Filings and Audits by Year

Form 990 is an information return that most organizations claiming federal tax-exempt status must file yearly with the IRS. Nonprofit Explorer has IRS digitized Form 990 data for filings processed in 2012 and later. If this organization filed an amended return, it may not be reflected below. Duplicate download links may indicate a resubmission or amendment to this organization's original return. Form 990 data is from the IRS.

Audits are required to be submitted by nonprofit organizations that spend $750,000 or more in federal grant money in a fiscal year. "Single audits" look at the entire organization's finances and compliance, while other audits are program specific. Nonprofit Explorer has PDFs of audits for some nonprofits for fiscal year 2015 and later. Audit data is from the Federal Audit Clearinghouse.

Fiscal Year Ending June
2024

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$353,749,327
Expenses
$330,337,653
Net Income
$23,411,674
Net Assets
$562,734,079
Notable Sources of Revenue Percent of Total Revenue
Contributions $31,691,692
9.0%
Program Services $311,282,673
88.0%
Investment Income $9,832,826
2.8%
Bond Proceeds $0
Royalties $228,620
0.1%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $703,698
0.2%
Net Inventory Sales $0
Other Revenue $9,818
0.0%
Notable Expenses Percent of Total Expenses
Executive Compensation $5,557,610
1.7%
Professional Fundraising Fees $0
Other Salaries and Wages $137,323,819
41.6%
Assets/Debt
Total Assets $750,835,911
Total Liabilities $188,101,832
Net Assets $562,734,079
Compensation
Key Employees and Officers Compensation Related Other
Ronald T Piervincenzi (Chief Executive Officer & Ex Officio) $1,021,625 $0 $133,537
Jakob Venema (Evp & Chief Science Officer) $609,378 $0 $93,316
Anthony P Lakavage (Secretary & Svp Glbl Ea) $509,150 $0 $79,527
Amanda D Cowley (Svp Legal People Strategy) $508,482 $0 $73,873
Emily M Kaine (Svp, Gbl Health & Manufacturing Svcs) $507,279 $0 $47,056
Venkat Surendra Nath Koduru (Svp Regions & Program Ops.) $485,652 $0 $30,194
Stanley D Burhans (Chief Financial Officer & Svp, Ops) $480,371 $0 $77,392
Fouad Atouf (Svp, Sci Glob Bio) $414,734 $0 $51,329
Bruk Alemayehu (Svp, Global Lab & Technical Ops) $412,396 $0 $48,154
Debra J Perez (Chief Equity Officer) $411,456 $0 $43,987
Jennifer Devine (Svp, Doc Stds & Comp Policy) $408,257 $0 $31,973
Michael S Levy (Svp, Digital & Innovation) $382,355 $0 $43,694
Kenneth B Alexander Vp Dep (Gc (To 10/23);Vp Mng Aty Glb Lg Aff) $348,091 $0 $24,069
Nurisha R Wade Vp Hqs Coe ((To 12/23); Vp, Industry Programs) $347,977 $0 $35,815
Dennis E Doherty Md (Convention President) $0 $0 $0
Todd K Abraham Phd Mba (Treasurer) $0 $0 $0
Gregory E Amidon Phd (Pharmaceutical Sciences Trustee) $0 $0 $0
Gwen Darien (Public Trustee) $0 $0 $0
Richard J Gilfillan Md Mba (At Large Trustee) $0 $0 $0
Jesse L Goodman Md Mph (Medical Sciences Trustee) $0 $0 $0
Laura Herman Mba Ma (At Large Trustee) $0 $0 $0
Thomas Menighan Bspharmmba (At Large Trustee) $0 $0 $0
Krishna Reddy Nallamalla Md (At Large Trustee) $0 $0 $0
Stephen Ostroff Md (Medical Sciences Trustee) $0 $0 $0
Julio Sanchez Y Tepoz Mscsjd (At Large Trustee) $0 $0 $0

Document Links

Fiscal Year Ending June
2023

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$346,271,530
Expenses
$313,280,612
Net Income
$32,990,918
Net Assets
$510,895,212
Notable Sources of Revenue Percent of Total Revenue
Contributions $30,105,843
8.7%
Program Services $305,130,377
88.1%
Investment Income $9,877,318
2.9%
Bond Proceeds $0
Royalties $234,034
0.1%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $486,401
0.1%
Net Inventory Sales $0
Other Revenue $437,557
0.1%
Notable Expenses Percent of Total Expenses
Executive Compensation $4,558,851
1.5%
Professional Fundraising Fees $0
Other Salaries and Wages $132,662,776
42.3%
Assets/Debt
Total Assets $701,768,432
Total Liabilities $190,873,220
Net Assets $510,895,212
Compensation
Key Employees and Officers Compensation Related Other
Ronald T Piervincenzi (Chief Executive Officer & Ex Officio) $898,347 $0 $101,702
Jakob Venema (Evp & Chief Science Officer) $549,453 $0 $66,721
Amanda D Cowley (Svp Legal People Strategy) $465,868 $0 $57,967
Emily M Kaine (Svp, Ghms) $465,653 $0 $53,168
Anthony P Lakavage (Secretary & Svp Glbl Ea) $463,649 $0 $56,571
Venkat Surendra Nath Koduru (Svp Regions & Program Ops.) $450,579 $0 $9,091
Stanley D Burhans (Chief Financial Officer) $446,383 $0 $55,805
Bruk Alemayehu (Svp, Glto) $372,277 $0 $49,170
Jennifer Devine (Svp, Doc Stds & Comp Policy) $367,442 $0 $36,514
Dawn M Oram (Head Of Gpc (Thru Dec 2022)) $352,426 $0 $39,776
Michael S Levy (Svp, Digital & Innovation) $350,728 $0 $43,223
Fouad Atouf (Svp, Sci Glob Bio) $350,495 $0 $50,220
Robert L Anderson (Vp, Mktg Comms Exec) $326,364 $0 $33,811
Dennis E Doherty Md (Convention President) $0 $0 $0
Todd K Abraham Phd Mba (Treasurer) $0 $0 $0
Gregory E Amidon Phd (Pharmaceutical Sciences Trustee) $0 $0 $0
Gwen Darien (Public Trustee) $0 $0 $0
Richard J Gilfillan Md Mba (At Large Trustee) $0 $0 $0
Jesse L Goodman Md Mph (Medical Sciences Trustee) $0 $0 $0
Laura Herman Mba Ma (At Large Trustee) $0 $0 $0
Thomas Menighan Bspharmmba (At Large Trustee) $0 $0 $0
Krishna Reddy Nallamalla Md (At Large Trustee) $0 $0 $0
Stephen Ostroff Md (Medical Sciences Trustee) $0 $0 $0
Julio Sanchez Y Tepoz Mscsjd (At Large Trustee) $0 $0 $0
John Taylor Jd (At Large Trustee) $0 $0 $0

Document Links

Fiscal Year Ending June
2022

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$342,334,376
Expenses
$290,499,670
Net Income
$51,834,706
Net Assets
$461,447,064
Notable Sources of Revenue Percent of Total Revenue
Contributions $23,282,824
6.8%
Program Services $303,193,655
88.6%
Investment Income $9,021,112
2.6%
Bond Proceeds $0
Royalties $137,114
0.0%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $6,621,335
1.9%
Net Inventory Sales $0
Other Revenue $78,336
0.0%
Notable Expenses Percent of Total Expenses
Executive Compensation $6,219,877
2.1%
Professional Fundraising Fees $0
Other Salaries and Wages $115,305,027
39.7%
Assets/Debt
Total Assets $655,709,010
Total Liabilities $194,261,946
Net Assets $461,447,064
Compensation
Key Employees and Officers Compensation Related Other
Ronald T Piervincenzi (Chief Executive Officer & Ex Officio) $1,437,616 $0 $97,362
Jakob Venema (Evp & Chief Science Officer) $588,410 $0 $59,675
Stanley D Burhans (Chief Financial Officer) $542,444 $0 $46,985
Amanda D Cowley (Svp Legal People Strategy) $494,384 $0 $50,341
Anthony P Lakavage (Svp Glbl Ea) $484,286 $0 $47,950
Emily M Kaine (Svp, Ghms) $482,240 $0 $44,478
Bruk Alemayehu (Svp, Glto) $442,729 $0 $10,564
Jennifer Devine (Svp, Doc Stds & Comp Policy) $410,861 $0 $29,715
Deidre E Boulware (Vp, Global Hr (Thru Feb 2021)) $377,704 $0 $1,046
Michael S Levy (Svp, Dig & Innov) $360,148 $0 $34,186
Kenneth B Alexander (Vp, Deputy Gc) $344,107 $0 $34,047
Robert L Anderson (Vp, Mktg Comms Exec) $338,090 $0 $26,424
Dennis E Doherty Md (Convention President) $0 $0 $0
Todd K Abraham Phd Mba (Treasurer) $0 $0 $0
Gregory E Amidon Phd (Pharmaceutical Trustee) $0 $0 $0
Gwen Darien (Public Trustee) $0 $0 $0
Richard J Gilfillan Md Mba (At Large Trustee) $0 $0 $0
Jesse L Goodman Md Mph (Medical Sciences Trustee) $0 $0 $0
Laura Herman Mba Ma (At Large Trustee) $0 $0 $0
Thomas Menighan Bspharmmba (At Large Trustee) $0 $0 $0
Krishna Reddy Nallamalla Md (At Large Trustee) $0 $0 $0
Stephen Ostroff Md (Medical Sciences Trustee) $0 $0 $0
Julio Sanchez Y Tepoz Mscsjd (At Large Trustee) $0 $0 $0
John Taylor Jd (At Large Trustee) $0 $0 $0
Susan Winckler Rph Jd (Chair And Pharma Sci Trust) $0 $0 $0

Document Links

Fiscal Year Ending June
2021

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$331,132,598
Expenses
$285,960,328
Net Income
$45,172,270
Net Assets
$462,534,537
Notable Sources of Revenue Percent of Total Revenue
Contributions $12,769,050
3.9%
Program Services $303,225,858
91.6%
Investment Income $3,869,526
1.2%
Bond Proceeds $0
Royalties $199,670
0.1%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $11,068,494
3.3%
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $6,060,622
2.1%
Professional Fundraising Fees $0
Other Salaries and Wages $122,832,913
43.0%
Assets/Debt
Total Assets $667,918,646
Total Liabilities $205,384,109
Net Assets $462,534,537
Compensation
Key Employees and Officers Compensation Related Other
Ronald T Piervincenzi (Chief Executive Officer) $848,839 $0 $82,383
Jakob Venema (Evp & Chief Science Officer) $627,094 $0 $54,789
Salah D Kivlighn End 5220 (Svp, Global Smpo) $536,913 $0 $3,909
Samir Z Wahab End 7220 (Vp, Global Rsl) $518,069 $0 $21,654
Anthony P Lakavage (Secretary) $515,644 $0 $43,729
Stanley D Burhans (Chief Financial Officer) $432,701 $0 $42,594
Amanda D Cowley (Svp Legal People Strategy) $411,622 $0 $24,530
Emily M Kaine (Svp, Global Health) $402,359 $0 $18,673
Adetokunbo J Joseph End 720 (Vp, Global Compliance Ethics) $368,952 $0 $24,877
Bruk Alemayehu (Svp, Glto) $351,941 $0 $17,450
Jennifer Devine (Svp, Doc Stds & Comp Policy) $349,419 $0 $6,330
John B Atwater End 7220 (Senior Director, Verification Programs) $340,213 $0 $0
Hermes Van Der Lee End 920 (Svp, Global Lab Ops) $331,710 $0 $24,438
Gregory E Amidon Phd (Pharmaceutical Trustee) $0 $0 $0
Jesse L Goodman Md Mph (Medical Sciences Trustee) $0 $0 $0
Laura Herman Mba Ma (At Large Trustee) $0 $0 $0
Susan Winckler Bs Pharmjdfa (Chair And Pharma Sci Trustee) $0 $0 $0
Todd K Abraham Phd Mba (Treasurer) $0 $0 $0
Dennis E Doherty (President) $0 $0 $0
Gwen Darien (Public Trustee) $0 $0 $0
John Taylor (At Large Trustee) $0 $0 $0
Julio Sanchez Y Tepoz Mscs Jd (At Large Trustee) $0 $0 $0
Krishna Reddy Nallamalla Md (At Large Trustee) $0 $0 $0
Richard J Gilfillan Md Mba (At Large Trustee) $0 $0 $0
Stephen Ostroff Md (Medical Sciences Trustee) $0 $0 $0

Document Links

Fiscal Year Ending June
2020

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$318,679,360
Expenses
$305,692,076
Net Income
$12,987,284
Net Assets
$373,283,440
Notable Sources of Revenue Percent of Total Revenue
Contributions $9,078,335
2.8%
Program Services $305,245,294
95.8%
Investment Income $5,764,390
1.8%
Bond Proceeds $0
Royalties $225,605
0.1%
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$1,533,683
Net Inventory Sales $0
Other Revenue -$100,581
Notable Expenses Percent of Total Expenses
Executive Compensation $5,690,245
1.9%
Professional Fundraising Fees $0
Other Salaries and Wages $126,673,398
41.4%
Assets/Debt
Total Assets $558,856,219
Total Liabilities $185,572,779
Net Assets $373,283,440
Compensation
Key Employees and Officers Compensation Related Other
Ronald T Piervincenzi (Chief Executive Officer) $831,822 $0 $112,584
Scott P Henderson (Svp, Info & Svcs End 10/2/19) $757,624 $0 $40,476
Jakob Venema (Evp & Chief Science Officer) $503,389 $0 $78,956
Anthony P Lakavage (Secretary) $415,433 $0 $67,342
Stanley D Burhans (Chief Financial Offier) $410,400 $0 $66,574
Salah D Kivlighn (Svp, Global Smpo) $387,738 $0 $49,439
Emily M Kaine (Svp, Global Health) $367,194 $0 $44,671
Amanda D Cowley (General Counsel Beg. 1/2020) $354,744 $0 $45,043
Ben A Firschein (Dir, Gea Rsrch & Analysis) $349,644 $0 $25,809
Hermes Van Der Lee (Svp, Global Lab Ops) $348,568 $0 $42,216
Christine Stunyo (Svp Global Human Resources) $338,660 $0 $37,731
Jennifer Devine (Svp, Doc Stds & Comp Policy) $329,260 $0 $36,783
Susan S De Mars (Frmr Chf. Legal Off. End 1/19) $295,771 $0 $21,772
Jesse L Goodman Md (President) $0 $0 $0
Timothy R Franson Bs (Past President) $0 $0 $0
John E Courtney Phd (Treasurer) $0 $0 $0
Laura Herman Mba Ma (Public Trustee) $0 $0 $0
Robert J Meyer Md (Medical Sciences Trustee) $0 $0 $0
Gregory E Amidon Phd (Pharmaceutical Trustee) $0 $0 $0
Marilyn K Speedie Ph (Pharmaceutical Trustee) $0 $0 $0
Todd K Abraham Phd (At Large Trustee) $0 $0 $0
Gail R Wilensky Phd (At Large Trustee) $0 $0 $0
Satyanarayana Chava P (At Large Trustee) $0 $0 $0
Susan Winckler Bs Pha (Chair) $0 $0 $0
Paul Chew Md (Medical Sciences Trustee) $0 $0 $0

Document Links

Fiscal Year Ending June
2019

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$332,879,981
Expenses
$300,645,416
Net Income
$32,234,565
Net Assets
$359,430,001
Notable Sources of Revenue Percent of Total Revenue
Contributions $15,062,188
4.5%
Program Services $312,071,879
93.7%
Investment Income $5,719,223
1.7%
Bond Proceeds $0
Royalties $77,286
0.0%
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$275,782
Net Inventory Sales $0
Other Revenue $225,187
0.1%
Notable Expenses Percent of Total Expenses
Executive Compensation $4,987,050
1.7%
Professional Fundraising Fees $0
Other Salaries and Wages $113,817,788
37.9%
Assets/Debt
Total Assets $541,192,214
Total Liabilities $181,762,213
Net Assets $359,430,001
Compensation
Key Employees and Officers Compensation Related Other
Ronald T Piervincenzi (Ceo) $868,419 $0 $135,471
Jakob Venema (Evp, Chief Science Officer) $532,207 $0 $96,494
Susan S De Mars (Evp, Chief Legal Officer) $521,297 $0 $97,868
Anthony P Lakavage (Svp, Global External Affairs) $429,098 $0 $86,844
Stanley D Burhans (Cfo) $420,402 $0 $46,251
Scott P Henderson (Svp, Info And Services) $411,404 $0 $48,416
Salah D Kivlighn (Svp, Global Smpo) $402,324 $0 $47,508
Hermes Van Der Lee (Svp, Global Lab Ops) $356,929 $0 $40,930
Emily M Kaine (Svp, Global Public Health) $352,824 $0 $37,135
Bruk Alemayehu (Svp, Science) $347,568 $0 $41,819
Amanda Cowley (Svp, Strategy And Bd) $344,580 $0 $40,819
Jesse L Goodman Md Mph (President) $0 $0 $0
Timothy R Franson Bs Pharm Md (Past President) $0 $0 $0
John E Courtney Phd (Treasurer) $0 $0 $0
Laura Herman Mba Ma (Public Trustee) $0 $0 $0
Robert J Meyer Md (Medical Sciences Trustee) $0 $0 $0
Gregory E Amidon Phd (Pharmaceutical Trustee) $0 $0 $0
Marilyn K Speedie Phd (Pharmaceutical Trustee) $0 $0 $0
Todd K Abraham Ph D Mba (At Large Trustee) $0 $0 $0
Thomas R Temple Bs Pharm Ms (At Large Trustee) $0 $0 $0
Gail R Wilensky Ph D (At Large Trustee) $0 $0 $0
Satyanarayana Chava Ph D (At Large Trustee) $0 $0 $0
Susan Winckler Bs Pharm Jdfa (Chair) $0 $0 $0
Paul Chew Md (Medical Sciences Trustee) $0 $0 $0

Document Links

Fiscal Year Ending June
2018

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$324,239,675
Expenses
$280,048,886
Net Income
$44,190,789
Net Assets
$324,730,320
Notable Sources of Revenue Percent of Total Revenue
Contributions $15,639,809
4.8%
Program Services $301,027,589
92.8%
Investment Income $3,024,939
0.9%
Bond Proceeds $0
Royalties $127,965
0.0%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $3,795,829
1.2%
Net Inventory Sales $0
Other Revenue $623,544
0.2%
Notable Expenses Percent of Total Expenses
Executive Compensation $5,514,797
2.0%
Professional Fundraising Fees $0
Other Salaries and Wages $109,398,808
39.1%
Assets/Debt
Total Assets $496,726,502
Total Liabilities $171,996,182
Net Assets $324,730,320
Compensation
Key Employees and Officers Compensation Related Other
Ronald T Piervincenzi (Ceo) $807,704 $0 $105,528
Susan S De Mars (Evp, Chief Legal Officer) $491,120 $0 $75,144
Jakob Venema (Evp, Chief Science Officer) $487,730 $0 $76,111
Richard C Wailes (Evp, Coo Through 7/07/2017) $459,768 $0 $55,535
Anthony P Lakavage (Svp, Global External Affairs) $406,945 $0 $64,393
Patrick H Lukulay (Vp Gph Africa) $396,148 $0 $25,307
Scott P Henderson (Svp, Info And Services) $394,549 $0 $45,885
Stanley D Burhans (Svp, Cfo) $386,421 $0 $31,663
Salah D Kivlighn (Svp, Global Smpo) $373,378 $0 $43,923
Robert A Femia (Svp, Chemical Medicines) $356,365 $0 $41,094
Hermes Van Der Lee (Svp, Global Lab Ops) $335,610 $0 $40,193
Tina S Morris (Svp Compendial Science) $321,315 $0 $34,848
Emily Kaine (Svp Global Public Health) $291,747 $0 $34,821
Jesse L Goodman Md Mph (President) $0 $0 $0
Timothy R Franson Bs Pharm Md (Past President) $0 $0 $0
John E Courtney Ph D (Treasurer) $0 $0 $0
Laura Herman Mba Ma (Public Trustee) $0 $0 $0
Robert J Meyer Md (Medical Sciences Trustee) $0 $0 $0
Gregory E Amidon Ph D (Pharmaceutical Trustee) $0 $0 $0
Marilyn K Speedie Phd (Pharmaceutical Trustee) $0 $0 $0
Todd K Abraham Ph D Mba (At Large Trustee) $0 $0 $24,758
Thomas R Temple Bs Pharm Ms (At Large Trustee) $0 $0 $0
Gail R Wilensky Ph D (At Large Trustee) $0 $0 $0
Satyanara Chava Ph D (At Large Trustee) $0 $0 $0
Susan Winckler Bs Pharm Jdfa (At Large Trustee) $0 $0 $0

Document Links

Fiscal Year Ending June
2017

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$288,329,755
Expenses
$267,313,743
Net Income
$21,016,012
Net Assets
$283,172,895
Notable Sources of Revenue Percent of Total Revenue
Contributions $17,695,635
6.1%
Program Services $269,667,551
93.5%
Investment Income $2,649,059
0.9%
Bond Proceeds $0
Royalties $131,222
0.0%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $1,007,290
0.3%
Net Inventory Sales $0
Other Revenue -$2,821,002
Notable Expenses Percent of Total Expenses
Executive Compensation $3,620,317
1.4%
Professional Fundraising Fees $0
Other Salaries and Wages $106,448,918
39.8%
Assets/Debt
Total Assets $455,148,899
Total Liabilities $171,976,004
Net Assets $283,172,895
Compensation
Key Employees and Officers Compensation Related Other
Ronald T Piervincenzi (Ceo) $767,830 $0 $94,704
Vijayaraghavan Srinivasan (Former Evp, Chief Science Ofcr) $551,489 $0 $0
Jakob Venema (Evp, Chief Science Officer) $518,690 $0 $59,021
Richard C Wailes (Evp, Chief Operating Officer) $497,745 $0 $59,228
Susan S De Mars (Evp, Chief Legal Officer) $482,357 $0 $66,165
Anthony P Lakavage (Svp, Global External Affairs) $436,061 $0 $23,902
Robert A Femia (Svp, Chemical Medicines) $393,669 $0 $21,582
Scott P Henderson (Svp, Info And Services) $379,526 $0 $56,504
Salah D Kivlighn (Svp, Global Smpo) $379,388 $0 $8,225
Stanley D Burhans (Svp & Cfo) $361,915 $0 $5,436
Barbara B Hubert (Vp, Global Strat Cust Dvlpmnt) $332,946 $0 $38,629
Hermes Van Der Lee (Svp, Global Lab Ops) $326,132 $0 $46,324
Tina S Morris (Svp, Compendial Science) $308,702 $0 $36,512
Drew J Lutz (Vp, Administrative Services) $304,678 $0 $43,763
Jesse L Goodman Md Mph (President) $0 $0 $0
Timothy R Franson Bs Pharm Md (Past President) $0 $0 $0
John E Courtney Phd (Treasurer) $0 $0 $0
Laura Herman Mba Ma (Public Trustee) $0 $0 $0
Robert J Meyer Md (Medical Sciences Trustee) $0 $0 $0
Stephen P Spielberg Md Phd (Med Sci Trustee, To 11/2016) $0 $0 $0
Gregory E Amidon Phd (Pharmaceutical Trustee) $0 $0 $0
Marilyn K Speedie Phd (Pharmaceutical Trustee) $0 $0 $0
Todd K Abraham Phd Mba (At Large Trustee) $0 $0 $0
Thomas R Temple Bs Pharmms (At Large Trustee) $0 $0 $0
Gail R Wilensky Phd (At Large Trustee) $0 $0 $0

Document Links

Fiscal Year Ending June
2016

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$264,417,645
Expenses
$232,357,200
Net Income
$32,060,445
Net Assets
$245,907,617
Notable Sources of Revenue Percent of Total Revenue
Contributions $16,140,116
6.1%
Program Services $243,965,321
92.3%
Investment Income $2,797,734
1.1%
Bond Proceeds $0
Royalties $133,690
0.1%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $1,083,734
0.4%
Net Inventory Sales $0
Other Revenue $297,050
0.1%
Notable Expenses Percent of Total Expenses
Executive Compensation $4,029,830
1.7%
Professional Fundraising Fees $0
Other Salaries and Wages $89,561,753
38.5%
Assets/Debt
Total Assets $414,895,604
Total Liabilities $168,987,987
Net Assets $245,907,617
Compensation
Key Employees and Officers Compensation Related Other
Ronald T Piervincenzi (Ceo) $728,033 $0 $194,291
Susan S De Mars (Evp, Chief Legal Officer) $708,744 $0 $127,639
Roger L Williams Phd (Former Ceo) $624,186 $0 $59,888
Vijayaraghavan Srinivasan (Former Evp, Chief Science Ofcr) $478,918 $0 $39,539
Richard C Wailes (Evp, Chief Operating Officer) $449,721 $0 $66,662
Scott P Henderson (Svp, Info And Services) $381,663 $0 $53,726
Jakob Venema (Evp, Chief Science Officer) $374,537 $0 $12,197
Barbara B Hubert (Vp, Global Strat Cust Dvlpmnt) $322,819 $0 $37,534
Hermes Van Der Lee (Svp, Global Lab Ops) $322,333 $0 $42,310
Tina S Morris (Svp, Sci Global Biologics) $303,956 $0 $36,179
Kelly S Willis (Svp, Global Public Health) $291,569 $0 $22,142
Samir Wahab (Vp, Rsl) $285,905 $0 $44,322
Drew J Lutz (Vp, Administrative Services) $281,964 $0 $41,368
Jesse L Goodman Md Mph (President) $0 $0 $0
Timothy R Franson Bs Pharm Md (Past President) $0 $0 $0
John E Courtney Phd (Treasurer) $0 $0 $0
Laura Herman Mba Ma (Public Trustee) $0 $0 $0
Robert J Meyer Md (Medical Sciences Trustee) $0 $0 $0
Stephen P Spielberg Md Phd (Medical Sciences Trustee) $0 $0 $0
Gregory E Amidon Phd (Pharmaceutical Trustee) $0 $0 $0
Marilyn K Speedie Phd (Pharmaceutical Trustee) $0 $0 $0
Thomas R Temple Bs Pharm Ms (At Large Trustee) $0 $0 $0
Gail R Wilensky Phd (At Large Trustee) $0 $0 $0
Todd K Abraham Phd Mba (At Large Trustee) $0 $0 $0
Susan C Wincklerbs Pharmjdfa (At Large Trustee) $0 $0 $0

Document Links

Fiscal Year Ending June
2015

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$230,734,267
Expenses
$202,259,776
Net Income
$28,474,491
Net Assets
$227,832,604
Notable Sources of Revenue Percent of Total Revenue
Contributions $14,764,699
6.4%
Program Services $208,520,967
90.4%
Investment Income $4,276,865
1.9%
Bond Proceeds $0
Royalties $131,149
0.1%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $2,072,118
0.9%
Net Inventory Sales $0
Other Revenue $968,469
0.4%
Notable Expenses Percent of Total Expenses
Executive Compensation $3,175,539
1.6%
Professional Fundraising Fees $0
Other Salaries and Wages $77,816,257
38.5%
Assets/Debt
Total Assets $405,208,320
Total Liabilities $177,375,716
Net Assets $227,832,604
Compensation
Key Employees and Officers Compensation Related Other
Ronald T Piervincenzi (Ceo) $688,838 $0 $14,126
Roger L Williams Ph D (Outgoing Ceo) $625,796 $0 $59,016
Vijayaraghavan Srinivasan (Evp, Chief Science Officer) $532,450 $0 $61,268
Susan S De Mars (Evp, Chief Legal Officer) $507,280 $0 $66,034
Michael D Maves Md (Svp, Development) $437,867 $0 $39,861
Richard Wailes (Chief Op. Officer) $399,344 $0 $51,092
Scott Henderson (Sr.Vp Info And Services) $336,850 $0 $49,445
Angela Long (Sr.Vp Global Alliance & Org) $323,999 $0 $47,807
Kevin Hool (Vp Research & Innovation) $317,749 $0 $47,701
Todd Cecil (Vp, Chemical Medicines) $314,328 $0 $48,042
Barbara Hubert (Vp Sales & Marketing) $289,051 $0 $33,768
Hermes Van Der Lee (Svp Global Lab Ops) $270,901 $0 $26,741
Matthew Van Hook (Vp Global Legal Affairs) $255,899 $0 $30,715
Samir Wahab (Vp, Rsl) $255,882 $0 $40,618
James Thompson (Global Vp Fin/Act/Trs/Purch) $231,703 $0 $39,573
Susan Bach (Vp Human Resources) $227,539 $0 $28,726
Emily Kaine (Vp, Strategy) $123,077 $0 $10,162
Kelly Willis (Svp, Global Public Health) $29,423 $0 $1,473
Timothy R Franson Bs Pharm Md (President) $0 $0 $0
Rene H Bravo Mdfaap (Past President) $0 $0 $0
John E Courtney Ph D (Treasurer) $0 $0 $0
Robert M Russell Md (Medical Sciences Trustee) $0 $0 $0
Duane M Kirking Pharm D Ph D (Chair, Usp Board Of Trustees) $0 $0 $0
Marilyn K Speedie Phd (Pharmaceutical Trustee) $0 $0 $0
Carolyn H Asbury Scmph Ph D (Public Trustee) $0 $0 $0

Document Links

Fiscal Year Ending June
2014

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$203,209,707
Expenses
$196,869,494
Net Income
$6,340,213
Net Assets
$204,538,592
Notable Sources of Revenue Percent of Total Revenue
Contributions $9,085,654
4.5%
Program Services $184,631,934
90.9%
Investment Income $2,968,085
1.5%
Bond Proceeds $0
Royalties $140,874
0.1%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $5,705,746
2.8%
Net Inventory Sales $0
Other Revenue $677,414
0.3%
Notable Expenses Percent of Total Expenses
Executive Compensation $5,555,433
2.8%
Professional Fundraising Fees $0
Other Salaries and Wages $73,004,062
37.1%
Assets/Debt
Total Assets $365,933,521
Total Liabilities $161,394,929
Net Assets $204,538,592
Compensation
Key Employees and Officers Compensation Related Other
Vijayaraghavan Srinivasan (Evp, Chief Science Officer) $732,617 $0 $61,148
Roger L Williams Ph D (Outgoing Ceo) $726,002 $0 $74,444
Anthony Destefano (Vp General Chapters) $492,879 $0 $28,990
Susan S De Mars (Evp, Chief Legal Officer) $482,147 $0 $65,052
Brian Hendrix (Outgoing Chief Op. Officer) $388,061 $0 $48,472
Richard Wailes (Incoming Chief Op. Officer) $384,048 $0 $47,042
Stamatia Calomeris (Director, Comm & Design) $372,093 $0 $33,487
Scott Henderson (Sr.Vp Info And Services) $324,880 $0 $49,325
Angela Long (Sr.Vp Global Alliance & Org) $314,713 $0 $48,051
Kevin Hool (Vp Research & Innovation) $311,413 $0 $47,978
Barbara Hubert (Vp Sales & Marketing) $272,250 $0 $32,431
Todd Cecil (Vp, Chemical Medicines) $270,158 $0 $43,085
Matthew Van Hook (Vp Global Legal Affairs) $255,706 $0 $31,095
Hermes Van Der Lee (Svp Global Lab Ops) $247,862 $0 $25,497
Susan Bach (Vp Human Resources) $226,779 $0 $28,146
James Thompson (Vp Fin, Accounting & Treasury) $220,502 $0 $38,078
Shawn Dressman (Vp Chemical Medicines) $171,087 $0 $25,817
Michael D Maves Md (Med. Sciences Trustee/Svp Dev.) $119,010 $0 $5,596
Timothy R Franson Bs Pharm Md (President) $0 $0 $0
Rene H Bravo Mdfaap (Past President) $0 $0 $0
John E Courtney Ph D (Treasurer) $0 $0 $0
Robert M Russell Md (Medical Sciences Trustee) $0 $0 $0
Duane M Kirking Pharm D Ph D (Chair, Usp Board Of Trustees) $0 $0 $0
Marilyn K Speedie Phd (Pharmaceutical Trustee) $0 $0 $0
Carolyn H Asbury Sc Mph Ph D (Public Trustee) $0 $0 $0

Document Links

Fiscal Year Ending June
2013

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$184,074,691
Expenses
$177,395,302
Net Income
$6,679,389
Net Assets
$196,050,926
Notable Sources of Revenue Percent of Total Revenue
Contributions $10,666,763
5.8%
Program Services $165,964,538
90.2%
Investment Income $2,733,940
1.5%
Bond Proceeds $0
Royalties $136,815
0.1%
Rental Property Income $23,826
0.0%
Net Fundraising $0
Sales of Assets $1,262,719
0.7%
Net Inventory Sales $0
Other Revenue $3,286,090
1.8%
Notable Expenses Percent of Total Expenses
Executive Compensation $4,550,851
2.6%
Professional Fundraising Fees $0
Other Salaries and Wages $65,686,436
37.0%
Assets/Debt
Total Assets $370,131,138
Total Liabilities $174,080,212
Net Assets $196,050,926

Document Links

Fiscal Year Ending June
2012

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$162,710,337
Expenses
$154,334,279
Net Income
$8,376,058
Net Assets
$185,684,856
Notable Sources of Revenue Percent of Total Revenue
Contributions $12,058,237
7.4%
Program Services $148,646,258
91.4%
Investment Income $2,891,244
1.8%
Bond Proceeds $0
Royalties $329,002
0.2%
Rental Property Income $101,126
0.1%
Net Fundraising $0
Sales of Assets -$1,315,530
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $2,856,358
1.9%
Professional Fundraising Fees $0
Other Salaries and Wages $57,696,782
37.4%
Assets/Debt
Total Assets $331,521,478
Total Liabilities $145,836,622
Net Assets $185,684,856

Document Links

Fiscal Year Ending June
2011

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$150,137,284
Expenses
$134,355,260
Net Income
$15,782,024
Net Assets
$178,314,220
Notable Sources of Revenue Percent of Total Revenue
Contributions $11,476,249
7.6%
Program Services $134,007,316
89.3%
Investment Income $3,032,225
2.0%
Bond Proceeds $0
Royalties $141,543
0.1%
Rental Property Income $97,241
0.1%
Net Fundraising $0
Sales of Assets $1,382,710
0.9%
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $3,521,467
2.6%
Professional Fundraising Fees $0
Other Salaries and Wages $48,514,703
36.1%
Assets/Debt
Total Assets $328,951,146
Total Liabilities $150,636,926
Net Assets $178,314,220

Document Links

Fiscal Year Ending June
2010

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending June
2009

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending June
2008

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending June
2007

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending June
2006

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending June
2005

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending June
2004

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending June
2003

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending June
2002

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

About This Data

Nonprofit Explorer includes summary data for nonprofit tax returns and full Form 990 documents, in both PDF and digital formats.

The summary data contains information processed by the IRS during the 2012-2019 calendar years; this generally consists of filings for the 2011-2018 fiscal years, but may include older records. This data release includes only a subset of what can be found in the full Form 990s.

In addition to the raw summary data, we link to PDFs and digital copies of full Form 990 documents wherever possible. This consists of separate releases by the IRS of Form 990 documents processed by the agency, which we update regularly.

We also link to copies of audits nonprofit organizations that spent $750,000 or more in Federal grant money in a single fiscal year since 2016. These audits are copied from the Federal Audit Clearinghouse.

Which Organizations Are Here?

Every organization that has been recognized as tax exempt by the IRS has to file Form 990 every year, unless they make less than $200,000 in revenue and have less than $500,000 in assets, in which case they have to file form 990-EZ. Organizations making less than $50,000 don’t have to file either form but do have to let the IRS they’re still in business via a Form 990N "e-Postcard."

Nonprofit Explorer has organizations claiming tax exemption in each of the 27 subsections of the 501(c) section of the tax code, and which have filed a Form 990, Form 990EZ or Form 990PF. Taxable trusts and private foundations that are required to file a form 990PF are also included. Small organizations filing a Form 990N "e-Postcard" are not included in this data.

Types of Nonprofits

There are 27 nonprofit designations based on the numbered subsections of section 501(c) of the tax code. See the list »

Get the Data

For those interested in acquiring the original data from the source, here’s where our data comes from:

  • Raw filing data. Includes EINs and summary financials as structured data.
  • Exempt Organization profiles. Includes organization names, addresses, etc. You can merge this with the raw filing data using EIN numbers.
  • Form 990 documents. Prior to 2017, these documents were obtained and processed by Public.Resource.org and ProPublica. Bulk PDF downloads since 2017 are available from the IRS.
  • Form 990 documents as XML files. Includes complete filing data (financial details, names of officers, tax schedules, etc.) in machine-readable format. Only available for electronically filed documents. Electronic data released prior to October 2021 is also available through Amazon Web Services.
  • Audits. PDFs of single or program-specific audits for nonprofit organizations that spent $750,000 or more in Federal grant money in a single fiscal year. Available for fiscal year 2015 and later.

API

The data powering this website is available programmatically, via an API. Read the API documentation »